Neurotrauma Reports,
Journal Year:
2024,
Volume and Issue:
5(1), P. 81 - 94
Published: Jan. 1, 2024
Major
determinants
of
the
biological
background
or
reserve,
such
as
age,
sex,
comorbidities
(diabetes,
hypertension,
obesity,
etc.),
and
medications
(e.g.,
anticoagulants),
are
known
to
affect
outcome
after
traumatic
brain
injury
(TBI).
With
unparalleled
data
richness
coronavirus
disease
2019
(COVID-19;
∼375,000
counting!)
well
chronic
form,
long-COVID,
also
called
post-acute
sequelae
SARS-CoV-2
infection
(PASC),
publications
(∼30,000
counting)
covering
virtually
every
aspect
diseases,
pathomechanisms,
biomarkers,
phases,
symptomatology,
etc.,
have
provided
a
unique
opportunity
better
understand
appreciate
holistic
nature
interconnectivity
between
organ
systems,
importance
in
modifying
trajectories
affecting
outcomes.
Such
approach
is
badly
needed
TBI-induced
conditions
their
totality.
Here,
I
briefly
review
what
about
long-COVID/PASC,
its
underlying—suspected—pathologies,
pathobiological
changes
induced
by
TBI,
other
words,
TBI
endophenotypes,
discuss
intersection
long-COVID/PASC
pathobiologies,
how
considering
some
factors
person's
inclusion
mechanistic
molecular
biomarkers
can
help
improve
clinical
management
patients.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(4), P. e063969 - e063969
Published: April 1, 2023
Objectives
Fatigue
is
a
pervasive
clinical
symptom
in
coronaviruses
and
may
continue
beyond
the
acute
phase,
lasting
for
several
months
or
years.
This
systematic
review
meta-analysis
aimed
to
incorporate
current
evidence
postinfection
fatigue
among
survivors
of
SARS-CoV-2
investigate
associated
factors.
Methods
Embase,
PsyINFO,
Medline,
CINAHL,
CDSR,
Open
Grey,
BioRxiv
MedRxiv
were
systematically
searched
from
January
2019
December
2021.
Eligible
records
included
all
study
designs
English.
Outcomes
vitality
adults
with
confirmed
diagnosis
measured
at
>30
days
post
infection.
Non-confirmed
cases
excluded.
JBI
risk
bias
was
assessed
by
three
reviewers.
Random
effects
model
used
pooled
proportion
95%
CIs.
A
mixed
meta-regression
35
prospective
articles
calculated
change
overtime.
Subgroup
analyses
explored
specific
group
characteristics
methodology.
Heterogeneity
using
Cochran’s
Q
I
2
statistic.
Egger’s
tests
publication
bias.
Results
Database
searches
returned
14
262
records.
Following
deduplication
screening,
178
identified.
147
(n=48
466
participants)
meta-analyses.
Pooled
prevalence
41%
(95%
CI:
37%
45%,
k=147,
=98%).
significantly
reduced
over
time
(−0.057,
−107
−0.008,
k=35,
=99.3%,
p=0.05).
higher
found
studies
valid
scale
(51%,
43%
58%,
k=36,
=96.2%,
p=0.004).
No
significant
difference
design
(p=0.272).
test
indicated
except
scales.
Quality
assessments
4%
low
bias,
78%
moderate
18%
high
risk.
Frequently
reported
associations
female
gender,
age,
physical
functioning,
breathlessness
psychological
distress.
Conclusion
revealed
that
experienced
following
their
Non-modifiable
factors
morbidity
contribute
ongoing
impede
recovery.
PROSPERO
registration
number
CRD42020201247.
Frontiers in Public Health,
Journal Year:
2023,
Volume and Issue:
11
Published: Feb. 16, 2023
Background
Post-acute
coronavirus
disease
2019
(COVID-19)
symptoms
occurred
in
most
of
the
COVID-19
survivors.
However,
few
studies
have
examined
issue
whether
hospitalization
results
different
post-acute
symptom
risks.
This
study
aimed
to
compare
potential
long-term
effects
hospitalized
and
non-hospitalized
Methods
is
designed
as
a
systematic
review
meta-analysis
observational
studies.
A
search
six
databases
was
performed
for
identifying
articles
published
from
inception
until
April
20th,
2022,
which
compared
risk
survivors
using
predesigned
strategy
included
terms
SARS-CoV-2
(eg,
COVID,
,
2019-nCoV
),
Syndrome
post-COVID,
post
COVID
conditions,
chronic
symptom,
long
long-haul
sequelae,
convalescence
persistent
(
hospitalized,
hospital
home-isolated
).
The
present
conducted
according
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
2020
statement
R
software
4.1.3
create
forest
plots.
Q
statistics
I
2
index
were
used
evaluate
heterogeneity
this
meta-analysis.
Results
Six
Spain,
Austria,
Switzerland,
Canada,
USA
involving
419
742
included.
number
ranged
63
431,
follow-up
data
collected
through
visits
four
another
two
an
electronic
questionnaire,
visit
telephone,
respectively.
Significant
increase
risks
dyspnea
(OR
=
3.18,
95%
CI
1.90–5.32),
anxiety
3.09,
1.47–6.47),
myalgia
2.33,
1.02–5.33),
hair
loss
2.76,
1.07–7.12)
found
with
outpatients.
Conversely,
persisting
ageusia
significantly
reduced
than
patients.
Conclusion
findings
suggested
that
special
attention
patient-centered
rehabilitation
service
based
on
needs
survey
should
be
provided
who
experienced
high
risk.
Frontiers in Public Health,
Journal Year:
2023,
Volume and Issue:
11
Published: March 9, 2023
Introduction
Many
people
experience
persistent
or
new-onset
symptoms
such
as
fatigue
cognitive
problems
after
an
acute
infection
with
COVID-19.
This
phenomenon,
known
long
COVID,
impacts
physical
and
mental
wellbeing,
may
affect
perceived
quality
of
life
occupational
perspectives
likewise.
The
aim
this
study
is
to
gain
a
deeper
understanding
how
COVID
health-related
restrictions
in
their
daily
situation,
identify
key
challenges
they
face.
Methods
Guided
qualitative
interviews
were
conducted
25
COVID.
transcribed
according
Dresing/Pehl
Kuckartz
analyzed
using
content
analysis.
Afterward,
systematic
comparison
the
data
reflection
under
consideration
lifeworld-theoretical
approaches
(Berger
Luckmann)
carried
out.
Results
revealed
that
many
participants
have
severe
which
strongly
impair
them
perform
work-related
activities,
personal
interests.
interviewees
already
reach
stress
limit
during
routine
household
activities
childcare.
Of
participants,
19
experienced
limitations
pursuing
leisure
10
23
jobs
reported
being
on
sick
leave
for
several
months.
Several
respondents
who
had
vocational
reintegration
are
still
affected
by
ongoing
work
performance
considerably.
leads
uncertainty,
role
conflicts,
decline
social
contacts,
decreased
incomes,
contribute
impairment
life.
Conclusions
shows
huge
need
specific
support
different
areas
To
prevent
from
finding
themselves
economic
precarity,
decision-makers
should
develop
strategies
systematically
sustainable
into
workforce.
focus
be
creating
COVID-sensitive
workplaces,
compensating
improving
access
relief
services
reintegration.
We
argue,
shift
necessary
considered
rather
“social
disease”
considerably
impairments
those
affected.
Trial
registration
registered
German
register
clinical
trials
(DRKS00026007).
BMC Health Services Research,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Oct. 26, 2023
Many
people
experience
long-term
symptoms
such
as
fatigue,
cognitive
problems,
or
shortness
of
breath
after
an
acute
infection
with
COVID-19.
This
emerging
syndrome,
known
long
COVID,
is
new
and
complex
in
many
aspects.
study
aims
to
collect
the
experiences
COVID
ambulatory
healthcare
structures.Four
focus
groups
were
conducted
a
total
23
adults
June
July
2022.
These
discussions
audio-recorded,
subsequently
transcribed,
analyzed
using
qualitative
content
analysis
Mayring
Kuckartz.Fourteen
out
19
participants
who
had
primary
care
encounter
regarding
their
did
not
perceive
it
helpful.
respondents
reported
that
general
practitioners
take
seriously
refer
them
specialists
made
therapeutic
recommendations.
However,
some
they
prescribed
non-pharmaceutical
therapies
(e.g.,
group
meetings
supported
by
psychotherapists,
occupational
therapy,
etc.)
improved
condition.
14
perceived
barriers
providers'
lack
awareness
poor
access
specialists,
specialized
clinics),
high
bureaucratic
hurdles
for
specific
services.
To
improve
medical
care,
suggested
campaigns
raise
among
providers
population,
increase
research
government
investments
development
treatment
structures
expanding
existing
services,
establishing
one-stop
shops
integrated
specialist
COVID.Several
implications
professionals
policymakers
can
be
derived
from
this
study:
(1)
should
seriously,
assume
coordinating
role,
make
referrals,
establish
contact
clinics;
(2)
planners
on
developing
interprofessional
evidence-based
approaches
COVID;
(3)
outpatient
clinics
expanded.
The
overarching
goal
must
develop
consistent
guidelines
diagnosis,
treatment.The
registered
German
register
clinical
trials
(DRKS00026007,
first
registration
09/09/2021).
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(21), P. 6554 - 6554
Published: Nov. 4, 2022
Long
COVID
is
a
clinical
syndrome
characterized
by
profound
fatigue,
neurocognitive
difficulties,
muscle
pain,
weakness,
and
depression,
lasting
beyond
the
3–12
weeks
following
infection
with
SARS-CoV-2.
Among
symptoms,
psychiatric
sequelae,
including
attention
memory
alterations,
as
well
anxiety
depression
have
become
major
targets
of
current
healthcare
providers
given
significant
public
health
impact.
In
this
context,
assessment
tools
play
crucial
role
in
early
screening
cognitive
alterations
due
to
COVID.
others,
general
tools,
such
Montreal
Cognitive
assessment,
more
specific
ones,
State
Trait
Inventory
Fatigue
Digit
Span,
may
be
help
investigating
main
alterations.
Moreover,
appropriate
neurorehabilitative
programs
using
methods
techniques
(conventional
and/or
advanced)
through
multidisciplinary
team
are
required
treat
COVID-19-related
behavioral
abnormalities.
narrative
review,
we
sought
describe
symptoms
provide
some
advice
for
treatment
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: June 14, 2024
Long
COVID
is
a
condition
that
develops
in
subset
of
patients
after
COVID-19
infection
comprising
symptoms
varying
severity
encompassing
multiple
organ
systems.
Currently,
long
without
consensus
on
formal
definition,
identifiable
biomarkers,
and
validated
treatment.
expected
to
be
long-term
chronic
for
associated
with
suffering
incapacity.
There
an
urgent
need
clear
management
guidelines
the
primary
care
provider,
who
essential
bridging
gap
more
specialized
improve
quality
life
functionality
their
living
COVID.
The
purpose
this
mini
review
provide
providers
latest
highlights
from
existing
literature
regarding
most
common
current
recommendations.
This
also
underutilized
interventions
stellate
ganglion
blocks
low-dose
naltrexone,
both
well-established
safety
profiles
demonstrated
some
COVID,
encourages
prompt
referral
interventional
pain
management.
BMC Health Services Research,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 8, 2025
Many
people
who
contract
the
SAR-CoV-2
virus
present
with
multiple
persistent
and
debilitating
physical,
cognitive
mental
health
symptoms
that
endure
beyond
acute
infection
period.
This
new
syndrome
-
generally
referred
to
as
long
COVID
negatively
affects
patients'
emotional
wellbeing
quality
of
life,
presents
a
major
challenge
for
treatment
providers.
Considering
lack
evidence-based
supports,
this
qualitative
descriptive
study
explores
experiences
Canadian
social
service
providers
working
individuals
COVID,
well
their
suggestions
intervention
development.
Twenty
between
ages
29
57
across
Canada
completed
virtual
individual
interviews
discuss
care
recommendations
COVID.
Participants
were
from
range
sectors,
including
primary
care,
rehabilitation,
health,
community
support.
Interviews
recorded,
transcribed,
analyzed
using
codebook
thematic
analysis.
Four
themes
illustrated
providers'
(1)
selecting
personalized
treatments
based
on
patient
presentation
similar
conditions
amidst
uncertainty;
services,
(2)
building
an
integrated
model
care;
(3)
providing
holistic
support
patients
families
through
psychoeducation
daily
living
resources;
(4)
caring
in
are
adopting
approaches
address
symptom
persistence
face
considerable
knowledge
gap.
A
comprehensive,
pathway
is
needed
physical
psychosocial
while
increasing
provider
preparedness
treat
complex
condition.
Journal of Brown Hospital Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
The
coronavirus
disease
(COVID-19)
pandemic
was
a
global
health
crisis
with
far-reaching
consequences.
Among
these
were
physical
and
mental
complications
that
emerged
weeks
or
even
months
after
the
initial
COVID-19
infection,
collectively
termed
“long
COVID”
“post-COVID
syndrome.”
Identifying
epidemiology,
risk
factors,
clinical
manifestations,
management
strategies
for
long
COVID
is
crucial
both
clinicians
patients,
which
focus
of
this
review.
prevalence
varies
across
studies,
generally
ranging
from
5%
to
20%.
Prominent
factors
include
female
sex,
older
age,
high
number
acute
symptoms,
lower
socioeconomic
status,
underlying
comorbidities
such
as
diabetes,
asthma,
chronic
obstructive
pulmonary
disease.
manifestations
are
diverse;
beyond
commonly
reported
symptoms
fatigue,
malaise,
ageusia,
anosmia,
neuropsychiatric
headache,
cognitive
deficits,
depression
also
potential
outcomes.
Although
there
currently
no
consensus
on
COVID,
multidisciplinary
care
teams
appropriate
referrals
follow-up
diagnostic
studies
essential
in
evaluating
course
patients.